Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
作者信息
Gladstone Douglas E, Kim Bo Soo, Mooney Kathy, Karaba Andrew H, D'Alessio Franco R
机构信息
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (D.E.G., K.M.).
Johns Hopkins University School of Medicine, Baltimore, Maryland (B.S.K., A.H.K., F.R.D.).
出版信息
Ann Intern Med. 2020 Nov 17;173(10):852-853. doi: 10.7326/L20-0681. Epub 2020 Jul 6.
Abstract
摘要
相似文献
1
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.用于治疗新冠肺炎和急性呼吸窘迫综合征患者的调节性T细胞：两例病例报告
Ann Intern Med. 2020 Nov 17;173(10):852-853. doi: 10.7326/L20-0681. Epub 2020 Jul 6.
2
Regulatory T Cells Tested in Patients With COVID-19 ARDS.在新冠病毒感染相关急性呼吸窘迫综合征患者中检测调节性T细胞。
JAMA. 2020 Aug 11;324(6):539. doi: 10.1001/jama.2020.13765.
3
Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.新型冠状病毒肺炎急性呼吸窘迫综合征俯卧位通气期间的生理变化
Ann Acad Med Singap. 2020 Jul;49(7):509-513.
4
Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19.用于新型冠状病毒肺炎所致急性呼吸窘迫患者的带储液器和呼气末正压的氧合装置（ODRPEEP）
Med Clin (Barc). 2020 Aug 14;155(3):133-134. doi: 10.1016/j.medcli.2020.04.010. Epub 2020 May 8.
5
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
6
Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute Respiratory Distress Syndrome.新型冠状病毒肺炎与非新型冠状病毒肺炎相关急性呼吸窘迫综合征的呼吸力学
Am J Respir Crit Care Med. 2020 Jul 15;202(2):287-290. doi: 10.1164/rccm.202004-1226LE.
7
Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.纤维蛋白衍生肽Bβ15 - 42（FX06）作为新型冠状病毒肺炎相关急性呼吸窘迫综合征重症患者的挽救治疗手段
Crit Care. 2020 Sep 24;24(1):574. doi: 10.1186/s13054-020-03293-8.
8
Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.病例23 - 2020：一名死于新型冠状病毒肺炎的76岁女性。
N Engl J Med. 2020 Jul 23;383(4):380-387. doi: 10.1056/NEJMcpc2004974. Epub 2020 Jul 8.
9
Successful treatment of patients severely ill with COVID-19.成功治疗新冠病毒肺炎重症患者。
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):650-653. doi: 10.5588/ijtld.20.0232.
10
Awake proning in Covid-19 pneumonia.新型冠状病毒肺炎的清醒俯卧位通气
Infez Med. 2020 Sep 1;28(3):453-455.
引用本文的文献
1
Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications.调节性T细胞的组织特异性作用：抑制机制及其他，以及自身免疫性疾病中新兴的治疗见解
Front Immunol. 2025 Aug 26;16:1650451. doi: 10.3389/fimmu.2025.1650451. eCollection 2025.
2
The Multifaceted Role of Regulatory T Cells in Sepsis: Mechanisms, Heterogeneity, and Pathogen-Tailored Therapies.调节性T细胞在脓毒症中的多方面作用：机制、异质性及病原体针对性疗法
Int J Mol Sci. 2025 Aug 1;26(15):7436. doi: 10.3390/ijms26157436.
3
Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months.6个月后老年人对SARS-CoV-2感染的免疫反应降低。
Front Immunol. 2025 May 9;16:1596065. doi: 10.3389/fimmu.2025.1596065. eCollection 2025.
4
AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia.在恶性肿瘤和病毒性肺炎期间，AMPK对于调节性T细胞（Treg）功能适应微环境应激是必需的。
J Clin Invest. 2025 Mar 18;135(9). doi: 10.1172/JCI179572. eCollection 2025 May 1.
5
T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19.急性 COVID-19 后一年，调节性 T 细胞亚群未恢复。
Int J Mol Sci. 2024 Nov 1;25(21):11759. doi: 10.3390/ijms252111759.
6
Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome.Notch4调节性T细胞和SARS-CoV-2病毒血症影响COVID-19的生存结果。
Allergy. 2025 Feb;80(2):557-569. doi: 10.1111/all.16333. Epub 2024 Oct 3.
7
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation.富含CXCR4的调节性T细胞优先归巢至骨髓并消除炎症。
iScience. 2024 Aug 27;27(9):110830. doi: 10.1016/j.isci.2024.110830. eCollection 2024 Sep 20.
8
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.调节性 T 细胞在白癜风中的作用及治疗进展：迷你综述。
Inflamm Res. 2024 Aug;73(8):1311-1332. doi: 10.1007/s00011-024-01900-w. Epub 2024 Jun 5.
9
Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes.多次再刺激的人脐带血来源的调节性T细胞维持稳定的表型和抑制功能，并预测其对自身免疫性糖尿病的治疗效果。
Diabetol Metab Syndr. 2024 Mar 21;16(1):71. doi: 10.1186/s13098-024-01277-0.
10
Improving regulatory T cell production through mechanosensing.通过机械感知提高调节性 T 细胞的产量。
J Biomed Mater Res A. 2024 Jul;112(7):1138-1148. doi: 10.1002/jbm.a.37702. Epub 2024 Mar 7.
本文引用的文献
1
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
2
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者：快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
3
CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.CD4+CD25+Foxp3+Tregs 可缓解小鼠实验性肺损伤，并存在于急性肺损伤的人类患者中。
J Clin Invest. 2009 Oct;119(10):2898-913. doi: 10.1172/JCI36498. Epub 2009 Sep 21.
Zotero 插件